Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CARLSMED, INC.CARL · Entity 5551 | Director · Chief IP Officer | January 28, 2026 | January 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CARLSMED, INC.
Report date January 28, 2026 · Filed January 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 982,562 |
Reported balance
After 2026-01-28 transaction · row 1
1 source rowRow 1 · 2026-01-28 · Grant · Acquired 44,977 · Balance 982,562 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 28, 2026 Filed Jan 30, 2026 22:23 UTC | CARLSMED, INC. CARL · Entity 5551 | GrantCommon Stock | 44,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-032073 · ownership.xml · nonDerivative · entry 1 Casey Niall · CIK 0002077161 · Director · Chief IP Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 982,562 F1 · shares: Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 00:28 UTC | CARLSMED, INC. CARL · Entity 5551 | ConversionSeries B Preferred Stock · Derivative | 3,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-098530 · ownership.xml · derivative · entry 3 Casey Niall · CIK 0002077161 · Director · Chief IP Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. F1 · price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. F1 · derivative.exercise_date: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. F1 · derivative.expiration_date: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. Read SEC document |
| July 24, 2025 Filed Jul 25, 2025 00:28 UTC | CARLSMED, INC. CARL · Entity 5551 | Exercise / conversionCommon Stock | 3,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-098530 · ownership.xml · nonDerivative · entry 1 Casey Niall · CIK 0002077161 · Director · Chief IP Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937,585 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: These securities were previously reported on a Form 3 filed by the Reporting Person as preferred stock of the Issuer. Each share of preferred stock of the Issuer converted into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1-to-1 basis without payment of additional consideration. The preferred stock has no expiration date. Read SEC document |
| July 22, 2025 Filed Jul 25, 2025 00:28 UTC | CARLSMED, INC. CARL · Entity 5551 | GrantStock Options (Right to Buy) · Derivative | 53,571 | $0.00 Strike: $15.00 | $0.00 |
DisclosureSEC source: 0000950170-25-098530 · ownership.xml · derivative · entry 2 Casey Niall · CIK 0002077161 · Director · Chief IP Officer, Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 166,049 Underlying: Common Stock · 53,571 shares Expires 2035-07-09 F2 · derivative.exercise_date: The unvested stock options are convertible into approximately 53,571 shares of the Issuer's common stock and will begin to vest in equal installments on each quarterly anniversary of July 22, 2025 (the "Grant Date"), such that all of the stock options will be vested on the fourth anniversary of the Grant Date, provided that the Reporting Person remains in continuous service through each applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.